The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.
作者信息
Isaksen Kathrine T, Beiske Klaus, Smeland Erlend B, Jørgensen Judit, Brodtkorb Marianne, Myklebust June Helen, Jerkeman Mats, Meriranta Leo, Karjalainen-Lindsberg Marja-Liisa, Leppä Sirpa, Scott David W, Holte Harald, Blaker Yngvild Nuvin
机构信息
Department of Cancer Immunology Institute for Cancer Research Oslo University Hospital Oslo Norway.
KG Jebsen Centre for B cell malignancies University of Oslo Oslo Norway.
出版信息
EJHaem. 2020 Dec 5;2(1):104-108. doi: 10.1002/jha2.109. eCollection 2021 Feb.
Abstract
摘要
Zotero 插件